Company profile: Vironova
1.1 - Company Overview
Company description
- Provider of solutions for sub-visible particle analysis, offering products and services used in the development of particles for vaccines, drug delivery and gene therapy, as well as viral safety testing and material quality control; founded in 2005 from interdisciplinary research at the Karolinska Institute in Stockholm, Sweden.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vironova
Accurion
HQ: Germany
Website
- Description: Provider of advanced instrumentation for imaging ellipsometry and brewster angle microscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accurion company profile →
Transferra Nanosciences
HQ: Canada
Website
- Description: Provider of Chemistry Manufacturing and Controls services to biotechnology and pharmaceutical companies, specializing in the development and manufacture of complex drug delivery systems using lipid nanoparticle science.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transferra Nanosciences company profile →
6K
HQ: United States
Website
- Description: Provider of engineered materials and sustainable production via its UniMelt microwave plasma system. Produces additive manufacturing metal powders and battery materials for EVs and grid storage, using circular-economy feedstocks (scrap metals, used batteries) to cut greenhouse gases, energy and water use, and promote domestic manufacturing independence across manufacturing, renewable energy, aerospace, and consumer electronics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 6K company profile →
Obducat
HQ: Sweden
Website
- Description: Provider of micro- and nanolithography solutions, technologies, products and processes for advanced micro- and nanopatterning of surfaces, supporting the development of sensor devices, medical devices, and optical and photonic devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Obducat company profile →
Nuformix
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical products developed using cocrystal technology in the United Kingdom, leveraging world-class capability and know-how in cocrystal discovery and development to yield multiple product opportunities with an accompanying intellectual property portfolio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nuformix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vironova
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vironova
2.2 - Growth funds investing in similar companies to Vironova
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vironova
4.2 - Public trading comparable groups for Vironova
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →